partners & collaborations
The SVS VQI collaborates with multiple organizations, including the American College of Cardiology (ACC), American Venous Forum (AVF), American Heart Association (AHA), Society for Vascular Medicine (SVM), Vascular Access Society of the Americas (VASA), Society for Vascular Ultrasound (SVU), many regional Vascular Societies, governmental regulatory agencies, device manufacturers, and payers. The Registry Assessment of Peripheral Interventional Devices (RAPID) is a public/private partnership which uses the strength of different societies (SVS, ACC, and SIR) and their registries to enhance device evaluation and to develop objective performance criteria for the endovascular treatment of lower- extremity arterial occlusive disease. SVS VQI also works with industry to provide clinically detailed data for device performance, post-market surveillance, and label expansion. SVS VQI has partnered with vascular registries from Europe and Asia to form the International Consortium of Vascular Registries (ICVR) to bring a global perspective to improving vascular care and device evaluation.
SVS VQI COllaboration
The Society for Vascular Surgery Vascular Quality Initiative® (VQI®) is a collaboration of the Society for Vascular Surgery Patient Safety Organization (SVS PSO), 18 regional quality improvement groups organized under the SVS PSO, and Fivos, its commercial technology partner.
Societal Endorsement of SVS VQI
Quality improvement is a core mission of vascular professional societies. Numerous vascular societies support the SVS VQI as an ideal quality improvement initiative.
The SVS VQI works closely with industry using real-world registry data to advance the understanding of devices and therapies, improve patient safety, and streamline development.
Device and drug Manufacturers
By collaborating with the SVS VQI, industry has the opportunity to cost-effectively enroll a broad network of physicians and leverage a robust data collection platform to meet project objectives.
Manufacturers provide financial support to the SVS VQI on an annual basis at different levels, which helps to fund various VQI activities.
physicians and hospitals
The SVS PSO is partnering with the FDA and device manufacturers to use SVS VQI to help meet device regulatory requirements.
Vascular Technology Council (VTC)
The mission of the SVS VQI is to improve the quality, safety, effectiveness and cost of vascular health care by collecting and exchanging information.